London Stock Exchange ETF segment · UCITS ETF
Invest in DOCT ETF from India
Indian and foreign residents can buy Legal & General UCITS ETF Plc - Healthcare Breakthrough (DOCT) units directly through Paasa.
By Paasa · Updated
DOCT at a glance
- Price
- $18.37-$0.31 (1.67%)
- Expense ratio
- 0.49%
- Day range
- $18.20 – $18.61
- Assets
- $334.6M
- Domicile
- Ireland
- Holdings
- —
- Launched
- 2019
- Dividends
- —
- 1 month
- +3.75%
- 6 months
- +31.34%
- YTD
- +22.58%
- 1 year
- +41.67%
- 5 years
- -0.82%
Price change, excluding dividends.
Top 10 holdings
- 1TWIST BIOSCIENCE CORP USD 0.000012.9%
- 2GRAIL INC USD 0.012.8%
- 3NATERA INC USD 0.00012.4%
- 4TEMPUS AI INC USD 0.00012.4%
- 5ILLUMINA INC USD 0.012.2%
- 6INTUITIVE SURGICAL INC USD 0.0012.2%
- 7GUARDANT HEALTH INC USD 0.000012.1%
- 8THERMO FISHER SCIENTIFIC IN USD 1.02.1%
- 9MODERNA INC USD 0.00012.0%
- 10ADAPTIVE BIOTECHNOLOGIES USD 0.00012.0%
These 10 are 23.0% of the fund.
Where the money is invested
Sectors
- Healthcare98.8%
- Technology1.2%
Countries
- United States74.9%
- Switzerland6.7%
- United Kingdom5.2%
- Netherlands3.2%
- Hong Kong2.2%
- Germany1.8%
How to invest in DOCT from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.
Step 3
Search DOCT and buy
Find the fund by its ticker, DOCT, on the London Stock Exchange ETF segment, and place your order.
Why invest in DOCT from India
What DOCT holds
The primary goal of the L&G Healthcare Technology & Innovation UCITS ETF is to mirror the financial performance of the ROBO Global Healthcare Technology and Innovation Index TR.
Outside US estate tax
DOCT is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
Hold a dollar asset
DOCT is priced in US dollars, so a weaker rupee adds to what it's worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Why DOCT's UCITS structure matters for Indian investors
DOCT is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
Capital gains are taxed in India the same way as on a US-listed ETF.
Frequently asked questions
Can I buy DOCT from India?
Yes. Indian residents can buy Legal & General UCITS ETF Plc - Healthcare Breakthrough (DOCT) through Paasa. It is listed on the London Stock Exchange ETF segment and trades in US dollars. Your money leaves India under the RBI's Liberalised Remittance Scheme, and the units are held in your own name at Interactive Brokers.
What does DOCT invest in?
Its largest holdings are TWIST BIOSCIENCE CORP USD 0.00001 (2.9%), GRAIL INC USD 0.01 (2.8%) and NATERA INC USD 0.0001 (2.4%). Healthcare is its largest sector at 98.8%. The fund is domiciled in Ireland.
What is the expense ratio of DOCT?
Legal & General UCITS ETF Plc - Healthcare Breakthrough has an expense ratio of 0.49% a year, taken from the fund's assets rather than billed to you. The fund manages about $334.6M.
Is DOCT a UCITS ETF, and why does that matter for Indian investors?
Yes. Legal & General UCITS ETF Plc - Healthcare Breakthrough is a UCITS fund domiciled in Ireland. Because it is domiciled outside the US, it is not a US-situs asset, so US estate tax does not apply to it. On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
What tax do I pay in India when I sell DOCT?
In India, gains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation, and gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.